Therapeutics, a clinical-stage biotechnology company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to ETX-19477, the company's internally ...
Enrollment of pivotal cohort expected to begin in Q1 2026; ATSN-201 BLA submission on track for early 2028DURHAM, N.C., Jan. 08, 2026 (GLOBE ...
Your GMAT score is strong. Your GPA is solid. Your career accomplishments are impressive. But thousands of others equally as ...
First patient dosed in REVEAL pivotal trial evaluating TSHA-102 (N=15, aged 6 to <22 years) in Q4 2025, with enrollment ...
Money Talks News on MSN
15 short certificate programs that can open doors to higher-paying jobs
There are plenty of options for short certificate programs that pay well and balance accessibility with real professional ...
MapLight Therapeutics, Inc. (“MapLight”) (Nasdaq: MPLT) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to ML-007C-MA, an investigational novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback